1. Heim, M.E. (1993) Platinum and non-platinum complexes in clinical trials. Current status and new developments, in Keppler, B.K. (ed.). Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, pp. 9–24.
2. Gielen, M. (1994) Tin-based antitumor drugs, Metal Based Drugs
1, 213–219. b) Gielen, M. (1995) Tin-based antitumor drugs: new developments, Metal Based Drugs
2, 99-102.
3. Sadler, P.J. and Rodney, E.S. (1994) The chemistry of gold drugs, Metal Based Drugs
1, 107–144.
4. Köpf-Maier, P. (1993) Antitumor bis(cyclopentadienyl)metal complexes, in Keppler, B.K. (ed.), Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, pp. 259–296. b) Keppler, B.K., Friesen, C., Vongerichten, H. and Vogel, E. (1993) Budotitane, a new tumor-inhibiting titanium compound: preclinical and clinical development, in Keppler, B.K. (ed.), Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, pp. 297-323.
5. Clarke, M.J. (1993) Ruthenium complexes: potential role in anti-cancer pharmaceuticals, in Keppler, B.K. (ed.), Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, pp. 129–156.